Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update
May 29, 2018 08:00 ET | Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its financial statements and...
MediSix Therapeutics Launches with USD$20M Series A Financing
May 14, 2018 19:00 ET | Lightstone Ventures
SINGAPORE, May 14, 2018 (GLOBE NEWSWIRE) -- MediSix Therapeutics Pte. Ltd., a development-stage cell therapy company creating novel therapeutics to target T-cell leukemia and lymphoma, today...
Science 2 Startup Sy
Science 2 Startup Symposium Convened Over 230 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections that can Advance Scientific Innovation and Entrepreneurship
May 04, 2018 10:00 ET | Science2Startup
CAMBRIDGE, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Science 2 Startup, an invitation-only event, convened over 230 members of the biotech ecosystem at the Broad Institute of MIT and Harvard last...
Emerald Health Therapeutics to Launch Award-Winning Endocannabinoid Based Products into Canadian Grocery, Natural Health Product, and Pharmacy Stores
April 17, 2018 07:00 ET | Emerald Health Therapeutics Inc.
New joint venture, Emerald Health Naturals, secures exclusive Canadian rights to sell proprietary non-cannabis health products that support the human endocannabinoid system Initiative leverages...
Atlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research Institutions
April 12, 2018 09:00 ET | SV Health Investors
CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Boston-area venture capital firms Atlas Venture, F-Prime Capital Partners and SV Health Investors have partnered to create Science 2 Startup, an...
Sleep Apnea Devices Market worth over $9 billion by 2024: Global Market Insights, Inc.
March 07, 2018 05:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, March 07, 2018 (GLOBE NEWSWIRE) -- Global Sleep Apnea Devices Market is poised to cross USD 9 billion by 2024; according to a new research report by Global Market...
John Poss, Chief Executive Officer of GB Sciences, Inc., Returns to Uptick Newswire’s “Stock Day” Podcast with Everett Jolly for Operational Update
February 06, 2018 09:00 ET | GB Sciences, Inc.
PHOENIX, Feb. 06, 2018 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB:GBLX) (the “company”), discusses 2017 achievements and 2018 operations expectations, on Stock Day Podcast with Everett Jolly. “It...
Teneobio Announces a Strategic Alliance with TESARO to Develop the Next Generation of Immuno-Oncology, Multispecific Antibodies
January 08, 2018 08:00 ET | TeneoBio, Inc
MENLO PARK, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Teneobio, Inc., a next generation multi-specific antibody therapeutics company announced today the initiation of a research collaboration and...
Five Prime Therapeut
Five Prime Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
January 03, 2018 16:05 ET | Five Prime Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein...
Schrödinger and MaRS Innovation Announce the Launch of Bright Angel Therapeutics
December 21, 2017 08:00 ET | MaRS Innovation
New York, NY and Toronto Canada, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, and...